Tysabri Concentrate for Solution for Infusion 300mg/15ml
Product details
Registration number: SIN14408P
Classification: Prescription Only
Active ingredients: Natalizumab
Strength: 300 mg/15mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: EISAI (SINGAPORE) PTE. LTD.
ATC code: L04AG03
HSA approval date: 11 September 2013
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Tysabri Concentrate for Solution for Infusion 300mg/15ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14408P
Classification: Prescription Only
What active ingredients and strength are recorded for Tysabri Concentrate for Solution for Infusion 300mg/15ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Natalizumab
Strength: 300 mg/15mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Tysabri Concentrate for Solution for Infusion 300mg/15ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Tysabri Concentrate for Solution for Infusion 300mg/15ml?
According to the HSA dataset updated 7 August 2026:
Registrant: EISAI (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for Tysabri Concentrate for Solution for Infusion 300mg/15ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG
Manufacturing country/countries: GERMANY
Where can I look up Tysabri Concentrate for Solution for Infusion 300mg/15ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14408P or the exact product name Tysabri Concentrate for Solution for Infusion 300mg/15ml. The general register link does not preselect this product.
What are the source dates for this Tysabri Concentrate for Solution for Infusion 300mg/15ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Tysabri Concentrate for Solution for Infusion 300mg/15ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14408P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)